Evidence map›Paper›PMID 42719392›Full record

ReviewComprehensive physiology2026

Lung-Cardiovascular Interactions and Derangements in ARDS.

Pablo A Sanchez, Connor O'Brien, Matthieu Legrand, Carolyn S Calfee, Michael A Matthay

Abstract readReview
In one paragraph

Review in Comprehensive physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pablo A SanchezDivision of Cardiology, Department of Medicine University of California San Francisco San Francisco California USA.ORCID https://orcid.org/0000-0002-6324-5086
Connor O'BrienDivision of Cardiology, Department of Medicine University of California San Francisco San Francisco California USA.ORCID https://orcid.org/0000-0002-2325-8317
Matthieu LegrandDepartment of Anesthesiology University of California San Francisco San Francisco California USA.
Carolyn S CalfeeDepartment of Anesthesiology University of California San Francisco San Francisco California USA.
Michael A MatthayDepartment of Anesthesiology University of California San Francisco San Francisco California USA.ORCID https://orcid.org/0000-0003-3039-8155

Funding

Advancing Precision Medicine for ARDS and SepsisR35HL177135 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carolyn Calfee · 2025 to 2026
$2.3M
Role of Cardiac Dysfunction and Injury in High-Risk Acute Respiratory Distress Syndrome SubphenotypesF32HL160103 · NHLBI · STANFORD UNIVERSITY · PI SANCHEZ, PABLO · 2022 to 2022
$61k
NHLBI NIH HHS F32 HL160103NHLBI NIH HHS L30 HL165589NHLBI NIH HHS R35 HL177135
6 · The paper itself

Abstract

The acute respiratory distress syndrome (ARDS) is fundamentally characterized by alveolar injury, leading to lung edema, severe hypoxemia, and poorly compliant lungs. Alveolar and cardiovascular pathology are deeply intertwined in the syndrome, which can be marked by clinical cardiac, pulmonary, and systemic vascular abnormalities. Pulmonary vascular dysfunction is common even in the era of lung-protective ventilation, is associated with right ventricular (RV) dysfunction, and worse mortality. Frustratingly, these cardiovascular abnormalities pose management challenges for which we have limited targeted therapies that improve clinical outcomes. Recent inroads disentangling patient heterogeneity in ARDS may offer a direct avenue connecting biological mechanisms to effective treatments. Throughout this review, we will examine the clinical involvement of the cardiovascular system in ARDS, grounded on pathological and biological studies, and review available evidence for potential targeted therapies.

Indexed as

acute respiratory distress syndrome (ARDS)microcirculationpulmonary vascularright ventriclesystemic vascular

Identifiers

PMID42719392
PMCPMC13554470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.